Brussels

• A Global, Open-label, Adaptive Design Study to Investigate the Efficacy and Safety of SerpinPC in Subjects With Severe Hemophilia A or Moder … Ended
  2022-502880-39-00 4 2023-11-13 Severe Hemophilia A or Moderately Severe to Severe Hemophilia B
• A Study to Learn if a Medicine That Reduces Stomach Acid Affects the Blood Level of Study Intervention Called Sisunatovir in Healthy Adults Ended
  2023-507116-12-00 3 2023-10-25 RSV
• A study to investigate safety and efficacy with SAR445514 in participants with relapsed/refractory multiple myeloma (RRMM) and relapsed/refr … Ended
  2022-502057-33-00 7 2023-10-02 Relapsed/refractory multiple myeloma
• Maternal determinants of infant immunity to pertussis (MADI-02) Ended
  2024-517893-73-00 6 2023-09-09 Whooping cough
• A Study to Learn How Different Manufactured Products of the Study Medicine Called Sisunatovir are Taken Up Into the Blood When Taken on an E … Ended
  2023-505228-79-00 3 2023-08-28 RSV (Respiratory Syncytial Virus)
• A Study to Learn About the Study Medication Called Etrasimod Mini Tablets, Including Its Taste, When Mixed With Applesauce, Chocolate Puddin … Ended
  2023-504411-32-00 3 2023-08-23 immune-mediated inflammatory disorders, including ulcerative colitis,
• A Study to Estimate the Effect of Multiple Doses of Carbamazepine on the PK of Single Dose Vepdegestrant in Healthy Adult Participants Ended
  2023-505881-27-00 3 2023-08-14 ER+/HER2 positive breast cancer
• A Study to Learn About the Study Medicine Called PF-07293893 in Healthy Adults, and How Different Doses of Study Medicine are Tolerated and … Ended
  2023-504921-37-00 1 2023-08-04 heart failure with preserved ejection fraction (HFpEF)
• A Study to Learn About the Taste Profiles of Different Suspensions of Study Medicine Called PF-07923568 in Healthy Adult Participants Ended
  2023-504924-24-00 3 2023-07-25 RSV (respiratory syncytial virus)
• ABTECT-1 – ABX464 Treatment Evaluation for ulcerative Colitis Therapy -1 Ended
  2022-500535-36-01 5 2023-06-12 Moderately to severely active ulcerative colitis
• A study to evaluate if aticaprant added to a current antidepressant and given up to one year is safe and would help improve depression. Ended
  2023-508163-74-00 5 2023-06-12 Major Depressive Disorder
• A Study to Learn About the Study Medicine Called Nirmatrelvir/Ritonavir in People Who are Healthy Volunteers Co-administered the Medicine Ro … Ended
  2023-503570-20-00 3 2023-06-02 coronavirus disease 2019 (COVID-19)
• Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Oral Ozanimod in Pediatric Participants with Moderately to Severely Active Crohn … Ended
  2023-508777-91-00 10 2023-05-16 Moderately to Severely Active Crohn's Disease
• Phase 3, Placebo-controlled, Double-blind Study Assessing Rocatinlimab (AMG 451) in Combination with Topical Corticosteroids and/or Topical … Ended
  2022-501585-22-00 5 2023-05-11 Atopic Dermatitis
• A Phase 1 Study Evaluating Relative Bioavailability of Sprinkled Ritlecitinib in Applesauce, Yoghurt, and Strawberry Jam and Evaluating the … Ended
  2022-502872-22-00 3 2023-04-28 Alopecia Areata, Rheumatoid Arthritis, Vitiligo, Ulcerative Colitis an
• Long-term Efficacy and Safety of Tozorakimab in Participants with Chronic Obstructive Pulmonary Disease with a History of Exacerbations. Ended
  2022-501063-41-00 5 2023-04-20 Chronic Obstructive Pulmonary Disease (COPD)
• Primary carE PPi dEprescRibing (PEPPER) trial Ended
  2022-502375-37-00 6 2023-04-16 heartburn
• First-in-human phase I/IIa study investigating inhaled CIS-DPI as add-on treatment in Stage IV NSCLC patients Ended
  2022-501183-17-00 7 2023-02-23 Non-Small Cell Lung Cancer
• A study to compare the efficacy of an intradermal and an intramuscular single-visit dosing regimen of the rabies vaccine in adults Ended
  2024-511506-22-00 5 2023-01-11 Rabies
• An Open-Label Extension Study for Patients who Previously Completed Study ISEE2008 (GATHER2) Ended
  2024-515185-13-00 5 2022-12-21 geographic atrophy
• Study of Nemvaleukin Alfa in Combination with Pembrolizumab Versus Investigator's Choice Chemotherapy in Patients with Platinum-Resistant Ep … Ended
  2024-513230-38-00 5 2022-12-15 Platinum-Resistant Epithelial Ovarian, Fallopian Tube, or Primary Peri
• A study to test the safety of MK-1654 and how well MK-1654 works in healthy infants Ended
  2022-500350-42-01 10 2022-11-07 Prevention of RSV
• Efficacy and Safety of AXL-Inhibitor bemcentinib for the Treatment of Moderate COVID-19 (AXL-SolidAct) Ended
  2022-500363-12-00 4 2022-08-24 SARS CoV-2 (COVID-19)
• Cohort study of human mpox virus disease Ended
  2022-501132-42-00 6 2022-08-02 Monkeypox virus disease

Showing 217–240 of 265 trials